Barcelona, Spain

Josep Lluis Parra Palau


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Diagnosis: The Contributions of Josep Lluis Parra Palau

Introduction

Josep Lluis Parra Palau, an esteemed inventor located in Barcelona, Spain, has made significant contributions to the field of oncology through his innovative research. With a focus on targeting the HER2 receptor, his work not only advances the understanding of cancer biology but also paves the way for new diagnostic and therapeutic methods.

Latest Patents

Josep holds a patent for "Antibodies against HER2 truncated variant CTF-611." This invention presents a method for diagnosing and treating cancers that express the HER2 receptor. The patent details antibodies or fragments that recognize a specific epitope of the HER2 receptor truncated form known as CTF-611. These antibodies are capable of distinguishing between the different truncated variants, making them crucial for accurate cancer diagnosis and targeted therapy.

Career Highlights

Throughout his career, Josep has been associated with renowned research institutions, including the Fundació Privada Institució Catalana de Recerca i Estudis Avançats and the Fundació Privada Institut d'Investigació Oncològica de Vall d'Hebron. His dedication to cancer research has not only increased scientific knowledge but also impacted therapeutic strategies for patients.

Collaborations

Josep's work has been enhanced through collaborations with notable colleagues such as Joaquin Arribas Lopez and Kim Pedersen. These partnerships foster a robust exchange of ideas and expertise, contributing to the advancement of cancer research and innovative treatment approaches.

Conclusion

Josep Lluis Parra Palau's innovative work in developing antibodies targeting the HER2 receptor demonstrates the critical intersection of invention and healthcare. His patent and collaborations signify a substantial leap forward in cancer diagnostics and therapeutics, underscoring the importance of ongoing research in the fight against cancer. As he continues to contribute to this vital field, his efforts will undoubtedly inspire future innovations and save countless lives.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…